Conversely, in osteoporosis induced by chronic obstructive pulmonary disease (COPD) and parathyroid hormone (PTH), a deficiency in IL-17A reduces bone loss by decreasing osteoclast activity and RANKL expression (96, 97). Here, PTH is linked to chronic obstructive pulmonary disease.